Controlled Trial of Plasma Exchange and Leukapheresis in Polymyositis and Dermatomyositis
Frederick W. Miller(National Institute of Environmental Health Sciences), Paul H. Plötz(National Institutes of Health), David Fraser(National Institute of Dental and Craniofacial Research), Mary E. Cronin(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Susan F. Leitman(Beverly Hospital), Marinos C. Dalakas(National and Kapodistrian University of Athens), Richard L. Leff, Jeanne E. Hicks(Pain and Rehabilitation Medicine), Robert Wesley(National Institutes of Health Clinical Center)
Cited by 334
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
|The Journal of Clinical Endocrinology & Metabolism|2005|711
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
|Proceedings of the National Academy of Sciences|2007|598